India has become one of the largest destinations for clinical research outsourcing in the last few years. According to a RNCOS latest research report, the number of patients per site for clinic trials is higher in India as compared to the US and European countries. Medical needs of a number of patients in the country remain unsatisfied. By getting themselves enrolled in clinical trials, these patients are able to access free medical care, tests and drugs, which they cannot afford otherwise. The patient recruitment for clinical trials in India is over three times faster, with companies saving 68% of the time as compared to the US. With this, the clinical trials market in India is expected to further grow stupendously.
In the research report, “Booming Clinical Trials Market in India”, it was observed that both government and private players have been proactively establishing a favorable environment for conducting clinical trials in India. In 2010, the clinical research in India contributed about 2.4% of the global clinical research outsourcing industry. The sector is likely to witness the entry of several small-sized domestic clinical research organizations into the market, which has a huge growth potential.